Article
Molecular pathogenesis of diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Sept 2005
Lossos Izidore S
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous clinicopathologic entity accounting for 30% of non-Hodgkin's lymphomas. The pathogenesis of DLBCL is complex and heterogeneous. Recent studies using analysis of global gene expression with DNA microarrays and the classical molecular approaches demonstrate presence of several DLBCL subtypes characterized by different cells of origin, cytogenetic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
